US Stock MarketDetailed Quotes

SNY Sanofi

Watchlist

56.900
-0.890-1.54%

Close Mar 21 16:00 ET

57.500
+0.600+1.05%

Post 20:01 ET

140.38BMarket Cap23.67P/E (TTM)

Sanofi Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sanofi Q4 2024 Earnings Date

Currency：EURJan 30, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	10.44B	7.63B	-2.81B
Miss Est.	-4.39%	+3.47%	-26.91%
EPS	0.34	0.27	-0.07
Miss Est.	+256.32%	+222.73%	-20.07%

Analyst Rating

Buy

Mar 21, 2025

Sanofi Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Jul 31, 2025	2025/Q2	-- / 10.189B	--
Apr 24, 2025	2025/Q1	-- / 9.790B	--
Jan 30, 2025	2024/Q4	10.564B / 10.440B	--
Oct 25, 2024	2024/Q3	13.438B / 12.670B	--
Jul 25, 2024	2024/Q2	10.745B / 10.377B	--

DatePeriodRevenue/EstimateEarnings Call

Jul 31, 20252025/Q2-- / 10.189B--

Apr 24, 20252025/Q1-- / 9.790B--

Jan 30, 20252024/Q410.564B / 10.440B--

Oct 25, 20242024/Q313.438B / 12.670B--

Jul 25, 20242024/Q210.745B / 10.377B--

Unlock Free Earnings Estimates

Open Account

Sanofi Earnings Reports

20-F: FY2024 Annual Report

Feb 13 13:49 ET

6-K: Q4 Sales Growth of 10.3%, 2024 Business EPS Guidance Exceeded, And Strong Business EPS Rebound Expected in 2025

Jan 30 09:56 ET

6-K: 15.7% Sales Growth Boosted by Earlier-Than-Anticipated Vaccine Sales; 2024 Business Eps Guidance Raised Due to Strong Business Performance

Oct 25, 2024 12:42 ET

6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

Jul 25, 2024 11:48 ET